Patients with PAH develop two problems: remodelling of the pulmonary arteries and right ventricular failure (owing to the increased pressure). This study in rats provided evidence that in this experimental model RVX-208 reduced the changes in vascular cells that underlie the remodelling and additionally supported the pumping function of the muscle of the right ventricle.